Literature DB >> 22266889

The genetics of mitochondrial disease.

Ryan L Davis1, Carolyn M Sue.   

Abstract

The discovery that defects in mitochondria and mitochondrial DNA could cause human disease has led to the development of a rapidly expanding group of disorders known as mitochondrial disease. Mitochondrial disease is so named because of the common feature of impaired mitochondrial function. The main function of the mitochondrion is to produce energy for the cell in the form of ATP. ATP is generated by the respiratory chain, a series of complex proteins that are located in the mitochondrial membrane, and are encoded for by both the mitochondrial and nuclear genomes. Consequently, mitochondrial disease can be caused by mutations in either mitochondrial or nuclear DNA. Given the distribution of mitochondria throughout the body, the specific properties of mitochondrial DNA, and the mitochondrion's dependence on nuclear genes for its normal function, the clinical presentation of mitochondrial disease can be highly variable. Thus, familiarity with typical clinical presentations and knowledge of the genes that contribute to mitochondrial function will aid the clinician in the recognition, diagnosis, and management of patients with this group of diverse disorders. © Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22266889     DOI: 10.1055/s-0031-1299790

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  12 in total

1.  Methylmalonic acidemia: a megamitochondrial disorder affecting the kidney.

Authors:  Zsuzsanna K Zsengellér; Nika Aljinovic; Lisa A Teot; Mark Korson; Nancy Rodig; Jennifer L Sloan; Charles P Venditti; Gerard T Berry; Seymour Rosen
Journal:  Pediatr Nephrol       Date:  2014-05-28       Impact factor: 3.714

Review 2.  OXPHOS mutations and neurodegeneration.

Authors:  Werner J H Koopman; Felix Distelmaier; Jan A M Smeitink; Peter H G M Willems
Journal:  EMBO J       Date:  2012-11-13       Impact factor: 11.598

3.  Visual pathways evaluation in Kearns Sayre syndrome: a diffusion tensor imaging study.

Authors:  Maria Camilla Rossi-Espagnet; Martina Lucignani; Luca Pasquini; Antonio Napolitano; Stefano Pro; Andrea Romano; Daria Diodato; Diego Martinelli; Daniela Longo
Journal:  Neuroradiology       Date:  2019-11-04       Impact factor: 2.804

4.  Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics.

Authors:  Lukas M Simon; Leonard C Edelstein; Srikanth Nagalla; Angela B Woodley; Edward S Chen; Xianguo Kong; Lin Ma; Paolo Fortina; Satya Kunapuli; Michael Holinstat; Steven E McKenzie; Jing-Fei Dong; Chad A Shaw; Paul F Bray
Journal:  Blood       Date:  2014-02-12       Impact factor: 22.113

5.  Kearns-Sayre syndrome presenting as isolated growth failure.

Authors:  Conisha Mone Holloman; Lynne A Wolfe; William A Gahl; Cornelius F Boerkoel
Journal:  BMJ Case Rep       Date:  2013-02-18

Review 6.  Current strategies towards therapeutic manipulation of mtDNA heteroplasmy.

Authors:  Claudia V Pereira; Carlos T Moraes
Journal:  Front Biosci (Landmark Ed)       Date:  2017-01-01

7.  Mitochondrial mutations in 12S rRNA and 16S rRNA presenting as chronic progressive external ophthalmoplegia (CPEO) plus: A case report.

Authors:  Zhan-Yun Lv; Xue-Mei Xu; Xiao-Fu Cao; Qian Wang; Da-Fang Sun; Wen-Jing Tian; Yan Yang; Yu-Zhong Wang; Yan-Lei Hao
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

8.  De Novo Mutation of m.3243A>G together with m.16093T>C Associated with Atypical Clinical Features in a Pedigree with MIDD Syndrome.

Authors:  Zhixin Jiang; Yinan Zhang; Jingbin Yan; Fengwen Li; Xinqian Geng; Huijuan Lu; Xiaoer Wei; Yanmei Feng; Congrong Wang; Weiping Jia
Journal:  J Diabetes Res       Date:  2019-04-04       Impact factor: 4.011

9.  The long and winding road: perspectives of people and parents of children with mitochondrial conditions negotiating management after diagnosis.

Authors:  Janet C Long; Stephanie Best; Sarah Hatem; Tahlia Theodorou; Toni Catton; Sean Murray; Jeffrey Braithwaite; John Christodoulou
Journal:  Orphanet J Rare Dis       Date:  2021-07-13       Impact factor: 4.123

10.  mitoTev-TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels.

Authors:  Claudia V Pereira; Sandra R Bacman; Tania Arguello; Ugne Zekonyte; Sion L Williams; David R Edgell; Carlos T Moraes
Journal:  EMBO Mol Med       Date:  2018-09       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.